Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
3 May 2024
| m 20:50 | Extranodal NK- and T-cell lymphoma, nasal type diffhist +154 Jwarner talk contribs →DEP & RT {{#subobject:d8a9eb|Regimen=1}} | ||||
| m 20:33 | Rhabdomyosarcoma, pediatric diffhist -182 Jwarner talk contribs | ||||
|
|
m 20:27 | Classical Hodgkin lymphoma 2 changes history -1,252 [Jwarner (2×)] | |||
| m |
|
20:27 (cur | prev) -1,368 Jwarner talk contribs →VEBEP {{#subobject:d7a2a6|Regimen=1}} | |||
| m |
|
20:21 (cur | prev) +116 Jwarner talk contribs →VEBEP {{#subobject:d7a2a6|Regimen=1}} | |||
| m 20:04 | Endometrial cancer diffhist +3 Jwarner talk contribs | ||||
| m 19:20 | Prostate cancer diffhist +137 Jwarner talk contribs | ||||
|
|
18:59 | Non-small cell lung cancer, squamous 2 changes history +4,715 [Jwarner (2×)] | |||
| m |
|
18:59 (cur | prev) +2,641 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf|Regimen=1}} | |||
|
|
18:54 (cur | prev) +2,074 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Pembrolizumab {{#subobject:1dc8a3|Regimen=1}} | ||||
| m 18:47 | Hepatocellular carcinoma diffhist +2,076 Jwarner talk contribs | ||||
| m 17:07 | Medulloblastoma diffhist +55 Jwarner talk contribs →Consolidation | ||||
| m 17:00 | HIV-associated lymphoma diffhist -24 Jwarner talk contribs →CNS therapy, prophylaxis {{#subobject:724xbj|Variant=1}} | ||||
|
|
m 16:52 | Ewing sarcoma, pediatric 2 changes history -69 [Jwarner (2×)] | |||
| m |
|
16:52 (cur | prev) +11 Jwarner talk contribs | |||
| m |
|
16:51 (cur | prev) -80 Jwarner talk contribs →COG AEWS1031 Regimen A | |||
| m 16:40 | Burkitt lymphoma diffhist -25 Jwarner talk contribs | ||||
| m 10:57 | Head and neck cancer diffhist +1,139 Jwarner talk contribs →Cisplatin & RT {{#subobject:c7061f|Regimen=1}} | ||||
| m 10:45 | Breast cancer, HER2-positive diffhist +1,725 Jwarner talk contribs | ||||
| m 10:42 | Cholangiocarcinoma diffhist +1,080 Jwarner talk contribs | ||||
2 May 2024
1 May 2024
| m 20:14 | Ovarian cancer diffhist +3 Jwarner talk contribs →Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab {{#subobject:a38gbb|Regimen=1}} | ||||
| m 15:53 | Nasopharyngeal carcinoma diffhist +6 Jwarner talk contribs | ||||
| m 13:47 | Breast cancer diffhist -167 Jwarner talk contribs →AC-T {{#subobject:633n67|Regimen=1}} | ||||
30 April 2024
| m 22:54 | Follicular lymphoma diffhist +751 Jwarner talk contribs →References | ||||
| m 19:46 | Breast cancer, HER2-positive diffhist +1,008 Jwarner talk contribs | ||||
|
|
17:35 | Multiple myeloma, relapsed-refractory 2 changes history +1,926 [Jwarner (2×)] | |||
|
|
17:35 (cur | prev) +1,912 Jwarner talk contribs →VTD {{#subobject:96881b|Regimen=1}} | ||||
| m |
|
17:27 (cur | prev) +14 Jwarner talk contribs →Regimen variant #2 {{#subobject:fc94h1|Variant=1}} | |||
|
|
m 13:11 | Soft tissue sarcoma 4 changes history +1,765 [Jwarner (4×)] | |||
| m |
|
13:11 (cur | prev) 0 Jwarner talk contribs →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}} | |||
| m |
|
13:07 (cur | prev) +1,701 Jwarner talk contribs →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}} | |||
| m |
|
12:58 (cur | prev) +44 Jwarner talk contribs →References | |||
| m |
|
11:33 (cur | prev) +20 Jwarner talk contribs →Cisplatin monotherapy {{#subobject:6e93fa|Regimen=1}} | |||
|
|
m 11:31 | Desmoid tumor 2 changes history +12 [Jwarner (2×)] | |||
| m |
|
11:31 (cur | prev) +19 Jwarner talk contribs | |||
| m |
|
11:29 (cur | prev) -7 Jwarner talk contribs →Nirogacestat monotherapy {{#subobject:f3agdc|Regimen=1}} | |||
|
|
m 11:27 | Breast cancer, triple negative 9 changes history +826 [Jwarner (9×)] | |||
| m |
|
11:27 (cur | prev) +86 Jwarner talk contribs | |||
| m |
|
11:05 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:04 (cur | prev) +25 Jwarner talk contribs →Carboplatin & Gemcitabine (GCb) {{#subobject:d46b34|Regimen=1}} | |||
| m |
|
11:03 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:02 (cur | prev) +2 Jwarner talk contribs →References | |||
| m |
|
11:01 (cur | prev) +44 Jwarner talk contribs →References | |||
| m |
|
11:00 (cur | prev) +46 Jwarner talk contribs →FEC-D {{#subobject:0cagj9|Regimen=1}} | |||
| m |
|
10:58 (cur | prev) +5 Jwarner talk contribs →Carboplatin & Docetaxel {{#subobject:82336a|Regimen=1}} | |||
| m |
|
10:56 (cur | prev) +614 Jwarner talk contribs →References | |||
29 April 2024
| m 23:32 | Cervical cancer diffhist +551 Jwarner talk contribs →Advanced or metastatic disease, subsequent lines of therapy | ||||
28 April 2024
| 21:59 | Low-grade glioma, pediatric diffhist +1,125 Jwarner talk contribs →Temozolomide monotherapy {{#subobject:7b66b|Regimen=1}} | ||||
| m 21:48 | Drug index diffhist +56 Jwarner talk contribs →T | ||||
|
|
m 12:28 | Upper tract urothelial carcinoma 2 changes history +1,619 [Jwarner (2×)] | |||
| m |
|
12:28 (cur | prev) +217 Jwarner talk contribs | |||
| m |
|
12:27 (cur | prev) +1,402 Jwarner talk contribs | |||